Healthcare provider profile · identity verified

David Paul Malone, M.D.

Internal Medicine · MATTHEWS, NC · NPI 1881676500

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	723	214
Amlodipine Besylate	Amlodipine Besylate	559	169
Levothyroxine Sodium	Levothyroxine Sodium	390	114
Losartan Potassium	Losartan Potassium	387	119
Simvastatin	Simvastatin	287	80
Lisinopril	Lisinopril	283	83
Metoprolol Succinate	Metoprolol Succinate	257	71
Rosuvastatin Calcium	Rosuvastatin Calcium	244	76
Omeprazole	Omeprazole	217	70
Tamsulosin Hcl	Tamsulosin Hcl	212	69
Allopurinol	Allopurinol	200	62
Pantoprazole Sodium	Pantoprazole Sodium	184	61
Sertraline Hcl	Sertraline Hcl	171	47
Metformin Hcl	Metformin Hcl	155	49
Eliquis	Apixaban	153	32
Alprazolam	Alprazolam	143	35
Potassium Chloride	Potassium Chloride	140	49
Prednisone	Prednisone	138	104
Zolpidem Tartrate	Zolpidem Tartrate	131	29
Ozempic	Semaglutide	120	18
Trazodone Hcl	Trazodone Hcl	119	39
Cefdinir	Cefdinir	116	107
Furosemide	Furosemide	115	42
Hydrochlorothiazide	Hydrochlorothiazide	113	35
Jardiance	Empagliflozin	107	28
Alendronate Sodium	Alendronate Sodium	98	27
Lorazepam	Lorazepam	88	18
Ezetimibe	Ezetimibe	87	28
Metformin Hcl Er	Metformin Hcl	86	24
Carvedilol	Carvedilol	85	28
Pravastatin Sodium	Pravastatin Sodium	85	27
Irbesartan	Irbesartan	84	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	21
Escitalopram Oxalate	Escitalopram Oxalate	81	29
Albuterol Sulfate Hfa	Albuterol Sulfate	80	30
Gabapentin	Gabapentin	75	27
Clonazepam	Clonazepam	69	19
Bupropion Xl	Bupropion Hcl	66	22
Synthroid	Levothyroxine Sodium	65	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	39
Metoprolol Tartrate	Metoprolol Tartrate	62	19
Fluticasone Propionate	Fluticasone Propionate	61	27
Finasteride	Finasteride	57	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	54	49
Famotidine	Famotidine	53	14
Benazepril Hcl	Benazepril Hcl	51	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	48	43
Duloxetine Hcl	Duloxetine Hcl	48	11
Montelukast Sodium	Montelukast Sodium	47	15
Tizanidine Hcl	Tizanidine Hcl	47	26
Tramadol Hcl	Tramadol Hcl	47	18
Cephalexin	Cephalexin	46	40
Esomeprazole Magnesium	Esomeprazole Magnesium	44	12
Azithromycin	Azithromycin	43	43
Citalopram Hbr	Citalopram Hydrobromide	42	14
Synjardy	Empagliflozin/Metformin Hcl	42	12
Meloxicam	Meloxicam	41	19
Clopidogrel	Clopidogrel Bisulfate	40	15
Ondansetron Hcl	Ondansetron Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	32	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Myrbetriq	Mirabegron	32	suppressed
Valacyclovir	Valacyclovir Hcl	31	16
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Atenolol	Atenolol	30	suppressed
Azelastine Hcl	Azelastine Hcl	30	12
Mirtazapine	Mirtazapine	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Glimepiride	Glimepiride	29	11
Fluconazole	Fluconazole	28	22
Diazepam	Diazepam	27	suppressed
Mounjaro	Tirzepatide	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	22	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	15
Buspirone Hcl	Buspirone Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Calcitriol	Calcitriol	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	14
Klor-Con M20	Potassium Chloride	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Estradiol	Estradiol	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Mupirocin	Mupirocin	13	13
Ranolazine Er	Ranolazine	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Temazepam	Temazepam	13	suppressed
Testosterone	Testosterone	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nystatin	Nystatin	11	11
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error